TY - JOUR
T1 - FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle
AU - Aghdasi, Bahman
AU - Ye, Keqiang
AU - Resnick, Adam
AU - Huang, Alex
AU - Ha, Hyo Chol
AU - Guo, Xin
AU - Dawson, Ted M.
AU - Dawson, Valina L.
AU - Snyder, Solomon H.
PY - 2001/2/27
Y1 - 2001/2/27
N2 - FKBP12, the 12-kDa FK506-binding protein, is a ubiquitous abundant protein that acts as a receptor for the immunosuppressant drug FK506, binds tightly to intracellular calcium release channels and to the transforming growth factor β (TGF-β) type 1 receptor. We now demonstrate that cells from FKBP12-deficient (FKBP12-/-) mice manifest cell cycle arrest in G1 phase and that these cells can be rescued by FKBP12 transfection. This arrest is mediated by marked augmentation of p21(WAF1/CIP1) levels, which cannot be further augmented by TGF-β1. The p21 up-regulation and cell cycle arrest derive from the overactivity of TGF-β receptor signaling, which is normally inhibited by FKBP12. Cell cycle arrest is prevented by transfection with a dominant-negative TGF-β receptor construct. TGF-β receptor signaling to gene expression can be mediated by SMAD, p38, and ERK/MAP kinase (extracellular signal-regulated kinase/mitogen-activated protein kinase) pathways. SMAD signaling is down-regulated in FKBP12-/- cells. Inhibition of ERK/MAP kinase fails to affect p21 up-regulation. By contrast, activated phosphorylated p38 is markedly augmented in FKBP12-/- cells and the p21 up-regulation is prevented by an inhibitor of p38. Thus, FKBP12 is a physiologic regulator of cell cycle acting by normally down-regulating TGF-β receptor signaling.
AB - FKBP12, the 12-kDa FK506-binding protein, is a ubiquitous abundant protein that acts as a receptor for the immunosuppressant drug FK506, binds tightly to intracellular calcium release channels and to the transforming growth factor β (TGF-β) type 1 receptor. We now demonstrate that cells from FKBP12-deficient (FKBP12-/-) mice manifest cell cycle arrest in G1 phase and that these cells can be rescued by FKBP12 transfection. This arrest is mediated by marked augmentation of p21(WAF1/CIP1) levels, which cannot be further augmented by TGF-β1. The p21 up-regulation and cell cycle arrest derive from the overactivity of TGF-β receptor signaling, which is normally inhibited by FKBP12. Cell cycle arrest is prevented by transfection with a dominant-negative TGF-β receptor construct. TGF-β receptor signaling to gene expression can be mediated by SMAD, p38, and ERK/MAP kinase (extracellular signal-regulated kinase/mitogen-activated protein kinase) pathways. SMAD signaling is down-regulated in FKBP12-/- cells. Inhibition of ERK/MAP kinase fails to affect p21 up-regulation. By contrast, activated phosphorylated p38 is markedly augmented in FKBP12-/- cells and the p21 up-regulation is prevented by an inhibitor of p38. Thus, FKBP12 is a physiologic regulator of cell cycle acting by normally down-regulating TGF-β receptor signaling.
UR - http://www.scopus.com/inward/record.url?scp=0035956972&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035956972&partnerID=8YFLogxK
U2 - 10.1073/pnas.041614198
DO - 10.1073/pnas.041614198
M3 - Article
C2 - 11226255
AN - SCOPUS:0035956972
SN - 0027-8424
VL - 98
SP - 2425
EP - 2430
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 5
ER -